tiprankstipranks
Rubius Therapeutics (RUBY)
OTHER OTC:RUBY
US Market

Rubius Therapeutics (RUBY) Dividend Date & History

220 Followers

Dividend Data

Last Ex-Dividend Date
Jan 02, 2024
Payment date​
Dec 29, 2023
Dividend Amount Per Share
$0.06
Notavailable
Dividend Yield
Sector: Healthcare
Sector Average: 1.499%
Payout Ratio
-25.56%
Dividend Growth​
4 months
Since 2024
Last 3 Months

Dividend Amount Per Share​

RUBY Dividend Yield Range

Currently, no data available
Please return soon. This page is being updated.

RUBY Dividend History

Ex-Date
Amount
Frequency
Declaration Date
Record Date
Payment Date
Jan 02, 2024$0.06Not AvailableDec 26, 2023Dec 29, 2023
The table shows Rubius Therapeutics’s dividend history, including amount per share, payout frequency, declaration, record, and payment dates.

FAQ

Does Rubius Therapeutics pay dividends?
Yes, RUBY has paid a dividend within the past 12 months.
    How much is Rubius Therapeutics's dividend?
    Rubius Therapeutics (RUBY) does not pay a dividend
    When is Rubius Therapeutics ex-dividend date?
    Rubius Therapeutics's previous ex-dividend date was on Jan 02, 2024. Rubius Therapeutics shareholders who own RUBY stock before this date received Rubius Therapeutics's last dividend payment of $0.06 per share on Dec 29, 2023. RUBY's next ex-dividend date has not been announced yet.
      When is Rubius Therapeutics dividend payment date?
      Rubius Therapeutics’s next quarterly payment date is on Dec 29, 2023, when Rubius Therapeutics shareholders who owned RUBY shares before Jan 02, 2024 received a dividend payment of $0.06 per share. Add RUBY to your watchlist to be reminded of RUBY's next dividend payment.
        Does Rubius Therapeutics have sufficient earnings to cover their dividend?
        Rubius Therapeutics (RUBY) does not pay a dividend.
        What's Included in PREMIUM?
        Make informed decisions based on Top Analysts' activity
        Know what industry insiders are buying
        Get actionable alerts from top Wall Street Analysts
        Find out before anyone else which stock is going to shoot up
        Get powerful stock screeners & detailed portfolio analysis